Meta-analysis reported a significant reduction in ventilator-free days, organ failures, length of stay in ICU, mortality rates as well as relevant improvements in oxygenation and clinical outcomes of ventilated patients with ALI/ARDS given EPA and γ-linolenic acid (Pontes-Arruda, Demichele, Seth, & Singer, 2008).